Psychedelics

Psychedelics in psychiatry: emerging research on psilocybin, MDMA and ketamine. Clinical evidence, treatment protocols and therapeutic potential.

Page 2

Recently published articles about Psychedelics

JCP
The Psychedelic Renaissance and Treatment-Resistant Depression with David Feifel, MD, PhD
Podcast

January 13, 2026

Dr. David Feifel discusses psilocybin's breakthrough potential for treatment-resistant depression, the psychedelic renaissance, and preparing for a new era in psychiatry.
,
A Single LSD-Derived Dose Curbs Anxiety in Landmark Trial
news

September 8, 2025

A single dose of the LSD-derived drug MM120 dramatically reduced anxiety symptoms in adults with generalized anxiety disorder.
JCP
Psychedelic Therapies: One Drug, Multiple Treatments: Reply to Modesto-Lowe et al
Letter to the Editor

September 1, 2025

The authors reply to a letter by Modesto-Lowe et al regarding their survey of psychedelic practitioners’ views on psychological support.
, , , et al
Could Psilocybin Help Parkinson’s Patients, Too?
news

May 1, 2025

New research suggests psilocybin could dramatically improve both mood and motor symptoms in Parkinson’s patients.
LSD Microdosing Doesn’t Appear to Help Treat Adult ADHD
news

March 19, 2025

A recent clinical trial found that microdosing LSD offers no significant benefit over a placebo in improving ADHD symptoms in adults.
JCP
Maintenance of Antidepressant Effect After 1 Dose of Psilocybin
Original Research

March 3, 2025

Over 52 weeks, a single administration of 25 mg psilocybin suggested longer maintenance of antidepressant effect than both 1 mg and 10 mg.
, , , et al
JCP
Psychological Support in Psychedelic Therapy
Original Research

February 5, 2025

The survey reveals differences of opinion among psychedelic researchers, with a slight trend toward preference for an emotive approach to psychological support.
, , , et al
Weekly Mind Reader: Clinicians Tackle Psychedelics
news

October 18, 2024

This week offers a deep dive into psychedelics, ADHD fluctuations, and efforts to curb adolescent inhalant use.
PCC
Talking to Your Patients About Psychedelics
Rounds in the General Hospital

October 15, 2024

Given the precipitous increase in both scientific publications and public interest in psychedelics, clinicians should learn more about how they work, what they might work for, and what their...
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to...
, , , et al
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.
Researchers Uncover How Psilocybin Works in the Brain
news

July 18, 2024

Psilocybin disrupts brain networks related to reflective thinking, offering potential therapeutic benefits for mental health issues.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe